Demo Drug Development Pharma Companies 
H1 Blog
JULY 30, 2024
We’re curious to see what will happen over the next 12 months and how pharma companies will respond.” The Impact of Draft Guidance on Drug Development As it stands, drug development is an expensive endeavor, costing approximately $2.3 Find out more by requesting a demo today.
H1 Blog
JULY 5, 2023
The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
H1 Blog
DECEMBER 11, 2024
Drug Policy There will be significant changes in clinical trials & drug development due to the Inflation Reduction Act. As pharmaceutical companies shift their focus toward fewer, high-value therapeutic areas in light of the IRAs drug price negotiations, the overall number of clinical trials will go down.
H1 Blog
MAY 4, 2023
Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.
Expert insights. Personalized for you.
59 
Let's personalize your content